Myelodysplastic syndromes (MDS) are highly heterogeneous clonal haematopoietic disorders. Allogeneic haematopoietic stem cell transplantation (HSCT)…
New research shows that maintaining a healthy weight following a monoclonal gammopathy of undetermined significance diagnosis may significantly reduce the risk of progression to multiple…
Fredrik Schjesvold, Head of the Oslo Myeloma Center, Oslo University Hospital, and Head of the Norwegian myeloma association joins the show.
View the programme for an outline of the engaging topics being presented at EAHAD 2025.
Are you a passionate healthcare professional with a talent for engaging and inspiring others? EMJ is looking for new hosts to lead our renowned podcast…
Anna Sureda, Institut Català d’Oncologia – Hospital Duran i Reynals, Barcelona, Spain and President of the EBMT joins the EMJ podcast
Study links older brain age to cognitive decline in sickle cell anemia and economic deprivation, offering new insights for intervention.
Register for the EAHAD 2025 Congress now to save on your seat and join us in Milan from 4-7 February.
Uncover the future of lymphoma care with Marc Hoffman, Professor, Hematologic Malignancies at the University of Kansas Medical Center.
Uncover the future of lymphoma care with Marc Hoffman, Professor, Hematologic Malignancies at the University of Kansas Medical Center.
A recent retrospective study has shed new light on the effectiveness of chimeric antigen receptor T cell therapy for patients with transformed indolent non-Hodgkin lymphoma
